KIF20A and neoplasm: In the light of these activities and because MKLP2 is found to be highly expressed in tumour tissue (Gasnereau et al., 2012), inhibition of MKLP2 by antimitotics has been explored, and small molecule inhibitors of MKLP2 have been shown to perturb mammalian cytokinesis (Tcherniuk et al., 2010; Labrière et al., 2016).